Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 14, 2026

A Caenorhabditis elegans Nutritional-status Based Copper Aversion Assay
Published on: July 26, 2017
1University of Nevada Reno 89503-2722.
Computer simulations accurately model human copper metabolism, including Wilson's disease (hepatolenticular degeneration) and Menkes' disease (steely-hair syndrome). The models suggest specific genetic defects underlying these copper metabolism disorders.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: